Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

M

Methodist Health System

Status

Active, not recruiting

Conditions

Outpatient Prescription Issues

Treatments

Other: outpatient prescription issues

Study type

Interventional

Funder types

Other

Identifiers

NCT06222424
045.PHA.2023.C

Details and patient eligibility

About

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Full description

Use of an EMP CPA, which allows for broad prescriptive authority, will assist Emergency Department (ED )workflow by preventing a significant volume of new prescriptions needing to be sent by physician and mid-level providers. Will improve rates of ED re-visits. In addition, this Collaborative Practice Agreement (CPA) will not be associated with a large volume of new prescription errors.

Enrollment

350 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.

Exclusion criteria

  • CPA actions were misclassified as discharge prescription issue resolutions.
  • Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
  • Patients documented to have left the ED against medical advice.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

350 participants in 1 patient group

Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023
Other group
Description:
Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.
Treatment:
Other: outpatient prescription issues

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems